PEAK6 Investments’s Eli Lilly LLY Stock Holding History

PEAK6 Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$603	Sell	1 -1	-50%	-$899	﹤0.01%	3374
2024 Q2	$2.21K	Hold	2	–	–	﹤0.01%	3379
2024 Q1	$1.83K	Sell	2 -6,359	-100%	-$4.53M	﹤0.01%	3823
2023 Q4	$3.71M	Buy	6,361 +1,228	+24%	+$717K	0.01%	1053
2023 Q3	$2.76M	Sell	5,133 -4,538	-47%	-$2.34M	0.01%	1109
2023 Q2	$4.54M	Sell	9,671 -8,064	-45%	-$3.38M	0.02%	703
2023 Q1	$6.09M	Buy	17,735 +17,732	+591,067%	+$5.98M	0.03%	613
2022 Q4	$1K	Sell	3 -1	-25%	-$355	﹤0.01%	4231
2022 Q3	$1K	Sell	4 -11,780	-100%	-$3.73M	﹤0.01%	4780
2022 Q2	$5.22M	Buy	+11,784	New	+$3.54M	0.01%	1339
2021 Q3	–	Sell	-3	Closed	-$740	–	5486
2021 Q2	$1K	Buy	+3	New	+$603	﹤0.01%	4961

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PEAK6 Investments's LLY Position: Q3 2024 in Review

PEAK6 Investments reduced its Eli Lilly (LLY) stake by 50% in Q3 2024, selling an estimated $899 and leaving 1 share worth $603. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

PEAK6 Investments first reported a position in LLY in Q2 2021 and has held it in 11 quarters since. The position peaked at $6.09M in Q1 2023. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

PEAK6 Investments held 1 share of Eli Lilly worth $603 as of Q3 2024.
PEAK6 Investments sold 1 Eli Lilly share in Q3 2024, an estimated $899.
Eli Lilly made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3374 holding.
PEAK6 Investments first reported a position in Eli Lilly in Q2 2021 and has held it in 11 quarters since.
PEAK6 Investments's Eli Lilly position peaked at $6.09M in Q1 2023.
3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.